Cellular and molecular immunologic mechanisms in patients with atopic dermatitis

Journal of Allergy and Clinical Immunology

Volumn 138, Issue 2, 2016, Pages 336-349

  Werfel, Thomas ^a   Allam, Jean Pierre ^b   Biedermann, Tilo ^c   Eyerich, Kilian ^c   Gilles, Stefanie ^c   Guttman Yassky, Emma ^d   Hoetzenecker, Wolfram ^e   Knol, Edward ^f   Simon, Hans Uwe ^g   Wollenberg, Andreas ^h   Bieber, Thomas ^b,i   Lauener, Roger ^i,j   Schmid Grendelmeier, Peter ^i,k   Traidl Hoffmann, Claudia ^c,i   Akdis, Cezmi A ^i,k  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d ROCKEFELLER UNIVERSITY   (United States)

^e CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^g UNIVERSITY OF BERN   (Switzerland)

^h UNIVERSITY OF MUNICH   (Germany)

ⁱ Hochgebirgsklinik Children s Allergy and Asthma Hospital   (Switzerland)

^j Children's Hospital of Eastern Switzerland   (Switzerland)

^k UNIVERSITY OF ZURICH   (Switzerland)

more..

Author keywords

adaptive; Atopic dermatitis; filaggrin; IgE; IL 13; IL 31; IL 4; innate; skin; skin barrier; TH2

Indexed keywords

ALLERGEN; DUPILUMAB; IMMUNOGLOBULIN E; CARRIER PROTEIN; FILAGGRIN; INTERMEDIATE FILAMENT PROTEIN; PROTEIN BINDING;

ADULT DISEASE; ATOPIC DERMATITIS; B LYMPHOCYTE; BASOPHIL; CELLULAR IMMUNITY; CHILDHOOD DISEASE; DENDRITIC CELL; DRUG EFFICACY; ENVIRONMENTAL FACTOR; EOSINOPHIL; HUMAN; INNATE IMMUNITY; LYMPHOID CELL; MAST CELL; MICROBIOME; PRIORITY JOURNAL; PRURITUS; PSORIASIS; REVIEW; SYSTEMIC DISEASE; T LYMPHOCYTE; AGE; CYTOLOGY; DERMATITIS, ATOPIC; ENVIRONMENTAL EXPOSURE; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM; MICROFLORA;

AGE FACTORS; ALLERGENS; CARRIER PROTEINS; DERMATITIS, ATOPIC; ENVIRONMENTAL EXPOSURE; HUMANS; IMMUNE SYSTEM; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNITY, INNATE; IMMUNOGLOBULIN E; INTERMEDIATE FILAMENT PROTEINS; MICROBIOTA; PROTEIN BINDING; PRURITUS; PSORIASIS;

EID: 84990851596     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2016.06.010     Document Type: Review

References (183)

1. 1 Bieber, T., Akdis, C., Lauener, R., Traidl-Hoffmann, C., Schmid-Grendelmeier, P., Schappi, G., et al. Global Allergy Forum and 3rd Davos Declaration 2015: Atopic dermatitis/Eczema: challenges and opportunities toward precision medicine. Allergy 71 (2016), 588–592.
2. 2 Bieber, T., Atopic dermatitis. N Engl J Med 358 (2008), 1483–1494.
3. 3 Alduraywish, S.A., Lodge, C.J., Campbell, B., Allen, K.J., Erbas, B., Lowe, A.J., The march from early life food sensitization to allergic disease: a systematic review and meta-analyses of birth cohort studies. J Allergy Clin Immunol 71 (2016), 77–89.
4. 4 Saunders, S.P., Moran, T., Floudas, A., Wurlod, F., Kaszlikowska, A., Salimi, M., et al. Spontaneous atopic dermatitis is mediated by innate immunity, with the secondary lung inflammation of the atopic march requiring adaptive immunity. J Allergy Clin Immunol 137 (2016), 482–491.
5. 5 Abuabara, K., Margolis, D.J., Do children really outgrow their eczema, or is there more than one eczema?. J Allergy Clin Immunol 132 (2013), 1139–1140.
6. 6 Deckert, S., Kopkow, C., Schmitt, J., Nonallergic comorbidities of atopic eczema: an overview of systematic reviews. Allergy 69 (2014), 37–45.
7. 7 Wang, H., Diepgen, T.L., Atopic dermatitis and cancer risk. Br J Dermatol 154 (2006), 205–210.
8. 8 Linos, E., Raine, T., Alonso, A., Michaud, D., Atopy and risk of brain tumors: a meta-analysis. J Natl Cancer Inst 99 (2007), 1544–1550.
9. 9 Niwa, Y., Sumi, H., Akamatsu, H., An association between ulcerative colitis and atopic dermatitis, diseases of impaired superficial barriers. J Invest Dermatol 123 (2004), 999–1000.
10. 10 Rosenbauer, J., Herzig, P., Giani, G., Atopic eczema in early childhood could be protective against Type 1 diabetes. Diabetologia 46 (2003), 784–788.
11. 11 Schmitt, J., Schwarz, K., Baurecht, H., Hotze, M., Folster-Holst, R., Rodriguez, E., et al. Atopic dermatitis is associated with an increased risk for rheumatoid arthritis and inflammatory bowel disease, and a decreased risk for type 1 diabetes. J Allergy Clin Immunol 137 (2016), 130–136.
12. 12 Lin, C.H., Wei, C.C., Lin, C.L., Lin, W.C., Kao, C.H., Childhood type 1 diabetes may increase the risk of atopic dermatitis. Br J Dermatol 174 (2016), 88–94.
13. 13 Silverberg, J.I., Association between adult atopic dermatitis, cardiovascular disease, and increased heart attacks in three population-based studies. Allergy 70 (2015), 1300–1308.
14. 14 Andersen, Y.M., Egeberg, A., Gislason, G.H., Hansen, P.R., Skov, L., Thyssen, J.P., Risk of myocardial infarction, ischemic stroke, and cardiovascular death in patients with atopic dermatitis. J Allergy Clin Immunol, 2016 [Epub ahead of print].
15. 15 Mansouri, Y., Guttman-Yassky, E., Immune pathways in atopic dermatitis, and definition of biomarkers through broad and targeted therapeutics. J Clin Med 4 (2015), 858–873.
16. 16 Jahnz-Rozyk, K., Targowski, T., Paluchowska, E., Owczarek, W., Kucharczyk, A., Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis. Allergy 60 (2005), 685–688.
17. 17 Raap, U., Wichmann, K., Bruder, M., Stander, S., Wedi, B., Kapp, A., et al. Correlation of IL-31 serum levels with severity of atopic dermatitis. J Allergy Clin Immunol 122 (2008), 421–423.
18. 18 Rebane, A., Runnel, T., Aab, A., Maslovskaja, J., Ruckert, B., Zimmermann, M., et al. MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes. J Allergy Clin Immunol 134 (2014), 836–847.e11.
19. 19 Rebane, A., Akdis, C.A., MicroRNAs: essential players in the regulation of inflammation. J Allergy Clin Immunol 132 (2013), 15–26.
20. 20 Fujita, H., Shemer, A., Suarez-Farinas, M., Johnson-Huang, L.M., Tintle, S., Cardinale, I., et al. Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsets. J Allergy Clin Immunol 128 (2011), 574–582 e1-12.
21. 21 Noda, S., Krueger, J.G., Guttman-Yassky, E., The translational revolution and use of biologics in patients with inflammatory skin diseases. J Allergy Clin Immunol 135 (2015), 324–336.
22. 22 Suarez-Farinas, M., Ungar, B., Correa da Rosa, J., Ewald, D.A., Rozenblit, M., Gonzalez, J., et al. RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications. J Allergy Clin Immunol 135 (2015), 1218–1227.
23. 23 Henseler, T., Christophers, E., Disease concomitance in psoriasis. J Am Acad Dermatol 32 (1995), 982–986.
24. 24 Eyerich, S., Onken, A.T., Weidinger, S., Franke, A., Nasorri, F., Pennino, D., et al. Mutual antagonism of T cells causing psoriasis and atopic eczema. N Engl J Med 365 (2011), 231–238.
25. 25 Quaranta, M., Knapp, B., Garzorz, N., Mattii, M., Pullabhatla, V., Pennino, D., et al. Intraindividual genome expression analysis reveals a specific molecular signature of psoriasis and eczema. Sci Transl Med, 6, 2014, 244ra90.
26. 26 Guenova, E., Skabytska, Y., Hoetzenecker, W., Weindl, G., Sauer, K., Tham, M., et al. IL-4 abrogates T(H)17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells. Proc Natl Acad Sci U S A 112 (2015), 2163–2168.
27. 27 Beck, L.A., Thaci, D., Hamilton, J.D., Graham, N.M., Bieber, T., Rocklin, R., et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N Engl J Med 371 (2014), 130–139.
28. 28 Hamilton, J.D., Suarez-Farinas, M., Dhingra, N., Cardinale, I., Li, X., Kostic, A., et al. Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis. J Allergy Clin Immunol 134 (2014), 1293–1300.
29. 29 Khattri, S., Shemer, A., Rozenblit, M., Dhingra, N., Czarnowicki, T., Finney, R., et al. Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology. J Allergy Clin Immunol 133 (2014), 1626–1634.
30. 30 Tintle, S., Shemer, A., Suarez-Farinas, M., Fujita, H., Gilleaudeau, P., Sullivan-Whalen, M., et al. Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response. J Allergy Clin Immunol 128 (2011), 583–593 e1-4.
31. 31 Eichenfield, L.F., Tom, W.L., Chamlin, S.L., Feldman, S.R., Hanifin, J.M., Simpson, E.L., et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol 70 (2014), 338–351.
32. 32 Malajian, D., Guttman-Yassky, E., New pathogenic and therapeutic paradigms in atopic dermatitis. Cytokine 73 (2015), 311–318.
33. 33 Leung, D.Y., Guttman-Yassky, E., Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches. J Allergy Clin Immunol 134 (2014), 769–779.
34. 34 Bieber, T., Atopic dermatitis 2.0: from the clinical phenotype to the molecular taxonomy and stratified medicine. Allergy 67 (2012), 1475–1482.
35. 35 Garmhausen, D., Hagemann, T., Bieber, T., Dimitriou, I., Fimmers, R., Diepgen, T., et al. Characterization of different courses of atopic dermatitis in adolescent and adult patients. Allergy 68 (2013), 498–506.
36. 36 Gittler, J.K., Shemer, A., Suarez-Farinas, M., Fuentes-Duculan, J., Gulewicz, K.J., Wang, C.Q., et al. Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. J Allergy Clin Immunol 130 (2012), 1344–1354.
37. 37 Czarnowicki, T., Esaki, H., Gonzalez, J., Malajian, D., Shemer, A., Noda, S., et al. Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA) T2/T1 cell imbalance, whereas adults acquire CLA T22/T22 cell subsets. J Allergy Clin Immunol 136 (2015), 941–951.e3.
38. 38 Suarez-Farinas, M., Dhingra, N., Gittler, J., Shemer, A., Cardinale, I., de Guzman Strong, C., et al. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis. J Allergy Clin Immunol 132 (2013), 361–370.
39. 39 Noda, S., Suarez-Farinas, M., Ungar, B., Kim, S.J., de Guzman Strong, C., Xu, H., et al. The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased Th17 polarization. J Allergy Clin Immunol 136 (2015), 1254–1264.
40. 40 Novak, N., Bieber, T., Allergic and nonallergic forms of atopic diseases. J Allergy Clin Immunol 112 (2003), 252–262.
41. 41 Muraro, A., Lemanske, R.F. Jr., Hellings, P.W., Akdis, C.A., Bieber, T., Casale, T.B., et al. Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol 137 (2016), 1347–1358.
42. 42 Janumpally, S.R., Feldman, S.R., Gupta, A.K., Fleischer, A.B. Jr., In the United States, blacks and Asian/Pacific Islanders are more likely than whites to seek medical care for atopic dermatitis. Arch Dermatol 138 (2002), 634–637.
43. 43 Silverberg, J.I., Hanifin, J.M., Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study. J Allergy Clin Immunol 132 (2013), 1132–1138.
44. 44 Wang, H., Papoiu, A.D., Coghill, R.C., Patel, T., Wang, N., Yosipovitch, G., Ethnic differences in pain, itch and thermal detection in response to topical capsaicin: African Americans display a notably limited hyperalgesia and neurogenic inflammation. Br J Dermatol 162 (2010), 1023–1029.
45. 45 Saeki, H., Tsunemi, Y., Fujita, H., Kagami, S., Sasaki, K., Ohmatsu, H., et al. Prevalence of atopic dermatitis determined by clinical examination in Japanese adults. J Dermatol 33 (2006), 817–819.
46. 46 Koga, C., Kabashima, K., Shiraishi, N., Kobayashi, M., Tokura, Y., Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol 128 (2008), 2625–2630.
47. 47 Khattri, S., Brunner, P.M., Garcet, S., Finney, R., Cohen, S.R., Oliva, M., et al. Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis. Exp Dermatol, 2016 [Epub ahead of print].
48. 48 Margolis, J.S., Abuabara, K., Bilker, W., Hoffstad, O., Margolis, D.J., Persistence of mild to moderate atopic dermatitis. JAMA Dermatol 150 (2014), 593–600.
49. 49 Czarnowicki, T., Gonzalez, J., Shemer, A., Malajian, D., Xu, H., Zheng, X., et al. Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population. J Allergy Clin Immunol 136 (2015), 104–115.e7.
50. 50 Nograles, K.E., Zaba, L.C., Shemer, A., Fuentes-Duculan, J., Cardinale, I., Kikuchi, T., et al. IL-22-producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol 123 (2009), 1244–1252.e2.
51. 51 Grice, E.A., Kong, H.H., Renaud, G., Young, A.C., Program, N.C.S., Bouffard, G.G., et al. A diversity profile of the human skin microbiota. Genome Res 18 (2008), 1043–1050.
52. 52 Oh, J., Byrd, A.L., Deming, C., Conlan, S., Program, N.C.S., Kong, H.H., et al. Biogeography and individuality shape function in the human skin metagenome. Nature 514 (2014), 59–64.
53. 53 Grice, E.A., Segre, J.A., The skin microbiome. Nat Rev Microbiol 9 (2011), 244–253.
54. 54 Kong, H.H., Oh, J., Deming, C., Conlan, S., Grice, E.A., Beatson, M.A., et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res 22 (2012), 850–859.
55. 55 Hanski, I., von Hertzen, L., Fyhrquist, N., Koskinen, K., Torppa, K., Laatikainen, T., et al. Environmental biodiversity, human microbiota, and allergy are interrelated. Proc Natl Acad Sci U S A 109 (2012), 8334–8339.
56. 56 Song, H., Yoo, Y., Hwang, J., Na, Y.C., Kim, H.S., Faecalibacterium prausnitzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis. J Allergy Clin Immunol 137 (2016), 852–860.
57. 57 Nylund, L., Nermes, M., Isolauri, E., Salminen, S., de Vos, W.M., Satokari, R., Severity of atopic disease inversely correlates with intestinal microbiota diversity and butyrate-producing bacteria. Allergy 70 (2015), 241–244.
58. 58 Franzke, C.W., Cobzaru, C., Triantafyllopoulou, A., Loffek, S., Horiuchi, K., Threadgill, D.W., et al. Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand-dependent terminal keratinocyte differentiation. J Exp Med 209 (2012), 1105–1119.
59. 59 Kobayashi, T., Glatz, M., Horiuchi, K., Kawasaki, H., Akiyama, H., Kaplan, D.H., et al. Dysbiosis and Staphylococcus aureus colonization drives inflammation in atopic dermatitis. Immunity 42 (2015), 756–766.
60. 60 Gueniche, A., Knaudt, B., Schuck, E., Volz, T., Bastien, P., Martin, R., et al. Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled clinical study. Br J Dermatol 159 (2008), 1357–1363.
61. 61 Kopfnagel, V., Harder, J., Werfel, T., Expression of antimicrobial peptides in atopic dermatitis and possible immunoregulatory functions. Curr Opin Allergy Clin Immunol 13 (2013), 531–536.
62. 62 Ong, P.Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347 (2002), 1151–1160.
63. 63 Howell, M.D., Gallo, R.L., Boguniewicz, M., Jones, J.F., Wong, C., Streib, J.E., et al. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 24 (2006), 341–348.
64. 64 Travers, J.B., Kozman, A., Mousdicas, N., Saha, C., Landis, M., Al-Hassani, M., et al. Infected atopic dermatitis lesions contain pharmacologic amounts of lipoteichoic acid. J Allergy Clin Immunol 125 (2010), 146–152 e1-2.
65. 65 Salimi, M., Barlow, J.L., Saunders, S.P., Xue, L., Gutowska-Owsiak, D., Wang, X., et al. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med 210 (2013), 2939–2950.
66. 66 Hammad, H., Lambrecht, B.N., Barrier epithelial cells and the control of type 2 immunity. Immunity 43 (2015), 29–40.
67. 67 Volz, T., Skabytska, Y., Guenova, E., Chen, K.M., Frick, J.S., Kirschning, C.J., et al. Nonpathogenic bacteria alleviating atopic dermatitis inflammation induce IL-10-producing dendritic cells and regulatory Tr1 cells. J Invest Dermatol 134 (2014), 96–104.
68. 68 Kaesler, S., Volz, T., Skabytska, Y., Koberle, M., Hein, U., Chen, K.M., et al. Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4-mediated suppression of IL-10. J Allergy Clin Immunol 134 (2014), 92–99.
69. 69 Skabytska, Y., Wolbing, F., Gunther, C., Koberle, M., Kaesler, S., Chen, K.M., et al. Cutaneous innate immune sensing of Toll-like receptor 2-6 ligands suppresses T cell immunity by inducing myeloid-derived suppressor cells. Immunity 41 (2014), 762–775.
70. 70 Navarini, A.A., French, L.E., Hofbauer, G.F., Interrupting IL-6-receptor signaling improves atopic dermatitis but associates with bacterial superinfection. J Allergy Clin Immunol 128 (2011), 1128–1130.
71. 71 Howell, M.D., Kim, B.E., Gao, P., Grant, A.V., Boguniewicz, M., DeBenedetto, A., et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 124 (2009), R7–R12.
72. 72 Skabytska, Y., Kaesler, S., Volz, T., Biedermann, T., The role of innate immune signaling in the pathogenesis of atopic dermatitis and consequences for treatments. Semin Immunopathol 38 (2016), 29–43.
73. 73 Trautmann, A., Akdis, M., Kleemann, D., Altznauer, F., Simon, H.U., Graeve, T., et al. T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Invest 106 (2000), 25–35.
74. 74 Rebane, A., Zimmermann, M., Aab, A., Baurecht, H., Koreck, A., Karelson, M., et al. Mechanisms of IFN-gamma-induced apoptosis of human skin keratinocytes in patients with atopic dermatitis. J Allergy Clin Immunol 129 (2012), 1297–1306.
75. 75 Bateman, E.A., Ardern-Jones, M.R., Ogg, G.S., Persistent central memory phenotype of circulating Fel d 1 peptide/DRB1*0101 tetramer-binding CD4+ T cells. J Allergy Clin Immunol 118 (2006), 1350–1356.
76. 76 Macaubas, C., Wahlstrom, J., Galvao da Silva, A.P., Forsthuber, T.G., Sonderstrup, G., Kwok, W.W., et al. Allergen-specific MHC class II tetramer+ cells are detectable in allergic, but not in nonallergic, individuals. J Immunol 176 (2006), 5069–5077.
77. 77 Wambre, E., Van Overtvelt, L., Maillere, B., Humphreys, R., von Hofe, E., Ferhat, L., et al. Single cell assessment of allergen-specific T cell responses with MHC class II peptide tetramers: methodological aspects. Int Arch Allergy Immunol 146 (2008), 99–112.
78. 78 Thepen, T., Langeveld-Wildschut, E.G., Bihari, I.C., van Wichen, D.F., van Reijsen, F.C., Mudde, G.C., et al. Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study. J Allergy Clin Immunol 97 (1996), 828–837.
79. 79 Werfel, T., Morita, A., Grewe, M., Renz, H., Wahn, U., Krutmann, J., et al. Allergen specificity of skin-infiltrating T cells is not restricted to a type-2 cytokine pattern in chronic skin lesions of atopic dermatitis. J Invest Dermatol 107 (1996), 871–876.
80. 80 Werfel, T., The role of leukocytes, keratinocytes, and allergen-specific IgE in the development of atopic dermatitis. J Invest Dermatol 129 (2009), 1878–1891.
81. 81 Wambre, E., DeLong, J.H., James, E.A., LaFond, R.E., Robinson, D., Kwok, W.W., Differentiation stage determines pathologic and protective allergen-specific CD4+ T-cell outcomes during specific immunotherapy. J Allergy Clin Immunol 129 (2012), 544–551 e1-7.
82. 82 Wambre, E., Delong, J.H., James, E.A., Torres-Chinn, N., Pfutzner, W., Mobs, C., et al. Specific immunotherapy modifies allergen-specific CD4(+) T-cell responses in an epitope-dependent manner. J Allergy Clin Immunol 133 (2014), 872–879.e7.
83. 83 Tam, H., Calderon, M.A., Manikam, L., Nankervis, H., Garcia Nunez, I., Williams, H.C., et al. Specific allergen immunotherapy for the treatment of atopic eczema. Cochrane Database Syst Rev(2), 2016, CD008774.
84. 84 Eyerich, S., Eyerich, K., Pennino, D., Carbone, T., Nasorri, F., Pallotta, S., et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 119 (2009), 3573–3585.
85. 85 Roesner, L.M., Heratizadeh, A., Begemann, G., Kienlin, P., Hradetzky, S., Niebuhr, M., et al. Der p1 and Der p2-specific T cells display a Th2, Th17, and Th2/Th17 phenotype in atopic dermatitis. J Invest Dermatol 135 (2015), 2324–2327.
86. 86 Hijnen, D., Knol, E.F., Gent, Y.Y., Giovannone, B., Beijn, S.J., Kupper, T.S., et al. CD8(+) T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-gamma, IL-13, IL-17, and IL-22. J Invest Dermatol 133 (2013), 973–979.
87. 87 Hennino, A., Jean-Decoster, C., Giordano-Labadie, F., Debeer, S., Vanbervliet, B., Rozieres, A., et al. CD8+ T cells are recruited early to allergen exposure sites in atopy patch test reactions in human atopic dermatitis. J Allergy Clin Immunol 127 (2011), 1064–1067.
88. 88 Balaji, H., Heratizadeh, A., Wichmann, K., Niebuhr, M., Crameri, R., Scheynius, A., et al. Malassezia sympodialis thioredoxin-specific T cells are highly cross-reactive to human thioredoxin in atopic dermatitis. J Allergy Clin Immunol 128 (2011), 92–99.e4.
89. 89 Heratizadeh, A., Mittermann, I., Balaji, H., Wichmann, K., Niebuhr, M., Valenta, R., et al. The role of T-cell reactivity towards the autoantigen alpha-NAC in atopic dermatitis. Br J Dermatol 164 (2011), 316–324.
90. 90 Roesner, L.M., Heratizadeh, A., Wieschowski, S., Mittermann, I., Valenta, R., Eiz-Vesper, B., et al. α-NAC-specific autoreactive CD8+ T cells in atopic dermatitis are of an effector memory type and secrete IL-4 and IFN-γ. J Immunol 196 (2016), 3245–3252.
91. 91 Novak, N., An update on the role of human dendritic cells in patients with atopic dermatitis. J Allergy Clin Immunol 129 (2012), 879–886.
92. 92 Nakajima, S., Igyarto, B.Z., Honda, T., Egawa, G., Otsuka, A., Hara-Chikuma, M., et al. Langerhans cells are critical in epicutaneous sensitization with protein antigen via thymic stromal lymphopoietin receptor signaling. J Allergy Clin Immunol 129 (2012), 1048–1055.e6.
93. 93 Mudde, G.C., Van Reijsen, F.C., Boland, G.J., de Gast, G.C., Bruijnzeel, P.L., Bruijnzeel-Koomen, C.A., Allergen presentation by epidermal Langerhans’ cells from patients with atopic dermatitis is mediated by IgE. Immunology 69 (1990), 335–341.
94. 94 Staudacher, A., Hinz, T., Novak, N., von Bubnoff, D., Bieber, T., Exaggerated IDO1 expression and activity in Langerhans cells from patients with atopic dermatitis upon viral stimulation: a potential predictive biomarker for high risk of eczema herpeticum. Allergy 70 (2015), 1432–1439.
95. 95 Kerschenlohr, K., Decard, S., Przybilla, B., Wollenberg, A., Atopy patch test reactions show a rapid influx of inflammatory dendritic epidermal cells in patients with extrinsic atopic dermatitis and patients with intrinsic atopic dermatitis. J Allergy Clin Immunol 111 (2003), 869–874.
96. 96 Wollenberg, A., Kraft, S., Hanau, D., Bieber, T., Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J Invest Dermatol 106 (1996), 446–453.
97. 97 Schuller, E., Oppel, T., Bornhovd, E., Wetzel, S., Wollenberg, A., Tacrolimus ointment causes inflammatory dendritic epidermal cell depletion but no Langerhans cell apoptosis in patients with atopic dermatitis. J Allergy Clin Immunol 114 (2004), 137–143.
98. 98 Wollenberg, A., Wagner, M., Gunther, S., Towarowski, A., Tuma, E., Moderer, M., et al. Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. J Invest Dermatol 119 (2002), 1096–1102.
99. 99 de Graauw, E., Beltraminelli, H., Simon, H.U., Simon, D., Eosinophilia in Dermatologic Disorders. Immunol Allergy Clin North Am 35 (2015), 545–560.
100. 100 Kiehl, P., Falkenberg, K., Vogelbruch, M., Kapp, A., Tissue eosinophilia in acute and chronic atopic dermatitis: a morphometric approach using quantitative image analysis of immunostaining. Br J Dermatol 145 (2001), 720–729.
101. 101 Leiferman, K.M., Ackerman, S.J., Sampson, H.A., Haugen, H.S., Venencie, P.Y., Gleich, G.J., Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis. N Engl J Med 313 (1985), 282–285.
102. 102 Soragni, A., Yousefi, S., Stoeckle, C., Soriaga, A.B., Sawaya, M.R., Kozlowski, E., et al. Toxicity of eosinophil MBP is repressed by intracellular crystallization and promoted by extracellular aggregation. Mol Cell 57 (2015), 1011–1021.
103. 103 Roth, N., Stadler, S., Lemann, M., Hosli, S., Simon, H.U., Simon, D., Distinct eosinophil cytokine expression patterns in skin diseases—the possible existence of functionally different eosinophil subpopulations. Allergy 66 (2011), 1477–1486.
104. 104 Morshed, M., Yousefi, S., Stockle, C., Simon, H.U., Simon, D., Thymic stromal lymphopoietin stimulates the formation of eosinophil extracellular traps. Allergy 67 (2012), 1127–1137.
105. 105 Simon, D., Aeberhard, C., Erdemoglu, Y., Simon, H.U., Th17 cells and tissue remodeling in atopic and contact dermatitis. Allergy 69 (2014), 125–131.
106. 106 Mashiko, S., Bouguermouh, S., Rubio, M., Baba, N., Bissonnette, R., Sarfati, M., Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis. J Allergy Clin Immunol 136 (2015), 351–359.e1.
107. 107 Otsuka, A., Kabashima, K., Mast cells and basophils in cutaneous immune responses. Allergy 70 (2015), 131–140.
108. 108 Ito, Y., Satoh, T., Takayama, K., Miyagishi, C., Walls, A.F., Yokozeki, H., Basophil recruitment and activation in inflammatory skin diseases. Allergy 66 (2011), 1107–1113.
109. 109 Morshed, M., Hlushchuk, R., Simon, D., Walls, A.F., Obata-Ninomiya, K., Karasuyama, H., et al. NADPH oxidase-independent formation of extracellular DNA traps by basophils. J Immunol 192 (2014), 5314–5323.
110. 110 Yousefi, S., Morshed, M., Amini, P., Stojkov, D., Simon, D., von Gunten, S., et al. Basophils exhibit antibacterial activity through extracellular trap formation. Allergy 70 (2015), 1184–1188.
111. 111 Czarnowicki, T., Gonzalez, J., Bonifacio, K.M., Shemer, A., Xiangyu, P., Kunjravia, N., et al. Diverse activation and differentiation of multiple B-cell subsets in patients with atopic dermatitis but not in patients with psoriasis. J Allergy Clin Immunol 137 (2016), 118–129.e5.
112. 112 Heeringa, J.J., Hajdarbegovic, E., Thio, H.B., van Zelm, M.C., Systemic B-cell abnormalities in patients with atopic dermatitis?. J Allergy Clin Immunol, 2016 [Epub ahead of print].
113. 113 Werfel, T., Kapp, A., Environmental and other major provocation factors in atopic dermatitis. Allergy 53 (1998), 731–739.
114. 114 Bieber, T., Novak, N., Pathogenesis of atopic dermatitis: new developments. Curr Allergy Asthma Rep 9 (2009), 291–294.
115. 115 Heratizadeh, A., Wichmann, K., Werfel, T., Food allergy and atopic dermatitis: how are they connected?. Curr Allergy Asthma Rep 11 (2011), 284–291.
116. 116 Niebuhr, M., Scharonow, H., Gathmann, M., Mamerow, D., Werfel, T., Staphylococcal exotoxins are strong inducers of IL-22: a potential role in atopic dermatitis. J Allergy Clin Immunol 126 (2010), 1176–1183.e4.
117. 117 Schoefer, Y., Schafer, T., Meisinger, C., Wichmann, H.E., Heinrich, J., Predictivity of allergic sensitization (RAST) for the onset of allergic diseases in adults. Allergy 63 (2008), 81–86.
118. 118 Darsow, U., Laifaoui, J., Kerschenlohr, K., Wollenberg, A., Przybilla, B., Wuthrich, B., et al. The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: a European multicenter study. Allergy 59 (2004), 1318–1325.
119. 119 Reekers, R., Busche, M., Wittmann, M., Kapp, A., Werfel, T., Birch pollen-related foods trigger atopic dermatitis in patients with specific cutaneous T-cell responses to birch pollen antigens. J Allergy Clin Immunol 104 (1999), 466–472.
120. 120 Werfel, T., Heratizadeh, A., Niebuhr, M., Kapp, A., Roesner, L.M., Karch, A., et al. Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber. J Allergy Clin Immunol 136 (2015), 96–103.e9.
121. 121 Langeveld-Wildschut, E.G., Thepen, T., Bihari, I.C., ven Reijsen, F.C., de Vries, I.J., Bruijnzeel, P.L., et al. Evaluation of the atopy patch test and the cutaneous late-phase reaction as relevant models for the study of allergic inflammation in patients with atopic eczema. J Allergy Clin Immunol 98 (1996), 1019–1027.
122. 122 Mommert, S., Gschwandtner, M., Gutzmer, R., Werfel, T., The role of the histamine H4 receptor in atopic dermatitis. Curr Allergy Asthma Rep 11 (2011), 21–28.
123. 123 Langeveld-Wildschut, E.G., Bruijnzeel, P.L., Mudde, G.C., Versluis, C., Van Ieperen-Van Dijk, A.G., Bihari, I.C., et al. Clinical and immunologic variables in skin of patients with atopic eczema and either positive or negative atopy patch test reactions. J Allergy Clin Immunol 105 (2000), 1008–1016.
124. 124 Sharquie, I.K., Al-Ghouleh, A., Fitton, P., Clark, M.R., Armour, K.L., Sewell, H.F., et al. An investigation into IgE-facilitated allergen recognition and presentation by human dendritic cells. BMC Immunol, 14, 2013, 54.
125. 125 McAleer, M.A., Irvine, A.D., The multifunctional role of filaggrin in allergic skin disease. J Allergy Clin Immunol 131 (2013), 280–291.
126. 126 Jarrett, R., Salio, M., Lloyd-Lavery, A., Subramaniam, S., Bourgeois, E., Archer, C., et al. Filaggrin inhibits generation of CD1a neolipid antigens by house dust mite-derived phospholipase. Sci Transl Med, 8, 2016, 325ra18.
127. 127 Irvine, A.D., McLean, W.H., Leung, D.Y., Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 365 (2011), 1315–1327.
128. 128 Seltmann, J., Roesner, L.M., von Hesler, F.W., Wittmann, M., Werfel, T., IL-33 impacts on the skin barrier by downregulating the expression of filaggrin. J Allergy Clin Immunol 135 (2015), 1659–1661.e4.
129. 129 Cornelissen, C., Marquardt, Y., Czaja, K., Wenzel, J., Frank, J., Luscher-Firzlaff, J., et al. IL-31 regulates differentiation and filaggrin expression in human organotypic skin models. J Allergy Clin Immunol 129 (2012), 426–433 e1-8.
130. 130 Thyssen, J.P., Kezic, S., Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis. J Allergy Clin Immunol 134 (2014), 792–799.
131. 131 Pellerin, L., Henry, J., Hsu, C.Y., Balica, S., Jean-Decoster, C., Mechin, M.C., et al. Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin. J Allergy Clin Immunol 131 (2013), 1094–1102.
132. 132 De Benedetto, A., Rafaels, N.M., McGirt, L.Y., Ivanov, A.I., Georas, S.N., Cheadle, C., et al. Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol 127 (2011), 773–786 e1-7.
133. 133 Kelleher, M.M., Dunn-Galvin, A., Gray, C., Murray, D.M., Kiely, M., Kenny, L., et al. Skin barrier impairment at birth predicts food allergy at 2 years of age. J Allergy Clin Immunol 137 (2016), 1111–1116.e8.
134. 134 Mollanazar, N.K., Smith, P.K., Yosipovitch, G., Mediators of chronic pruritus in atopic dermatitis: getting the itch out?. Clin Rev Allergy Immunol, 2015 [Epub ahead of print].
135. 135 Dou, Y.C., Hagstromer, L., Emtestam, L., Johansson, O., Increased nerve growth factor and its receptors in atopic dermatitis: an immunohistochemical study. Arch Dermatol Res 298 (2006), 31–37.
136. 136 Vergnolle, N., Ferazzini, M., D'Andrea, M.R., Buddenkotte, J., Steinhoff, M., Proteinase-activated receptors: novel signals for peripheral nerves. Trends Neurosci 26 (2003), 496–500.
137. 137 Steinhoff, M., Bienenstock, J., Schmelz, M., Maurer, M., Wei, E., Biro, T., Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus. J Invest Dermatol 126 (2006), 1705–1718.
138. 138 Jariwala, S.P., Abrams, E., Benson, A., Fodeman, J., Zheng, T., The role of thymic stromal lymphopoietin in the immunopathogenesis of atopic dermatitis. Clin Exp Allergy 41 (2011), 1515–1520.
139. 139 Li, M., Messaddeq, N., Teletin, M., Pasquali, J.L., Metzger, D., Chambon, P., Retinoid X receptor ablation in adult mouse keratinocytes generates an atopic dermatitis triggered by thymic stromal lymphopoietin. Proc Natl Acad Sci U S A 102 (2005), 14795–14800.
140. 140 Wilson, S.R., The, L., Batia, L.M., Beattie, K., Katibah, G.E., McClain, S.P., et al. The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell 155 (2013), 285–295.
141. 141 Cevikbas, F., Wang, X., Akiyama, T., Kempkes, C., Savinko, T., Antal, A., et al. A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: involvement of TRPV1 and TRPA1. J Allergy Clin Immunol 133 (2014), 448–460.
142. 142 Singer, E.M., Shin, D.B., Nattkemper, L.A., Benoit, B.M., Klein, R.S., Didigu, C.A., et al. IL-31 is produced by the malignant T-cell population in cutaneous T-Cell lymphoma and correlates with CTCL pruritus. J Invest Dermatol 133 (2013), 2783–2785.
143. 143 Hawro, T., Saluja, R., Weller, K., Altrichter, S., Metz, M., Maurer, M., Interleukin-31 does not induce immediate itch in atopic dermatitis patients and healthy controls after skin challenge. Allergy 69 (2014), 113–117.
144. 144 Silverberg, J.I., Hanifin, J., Simpson, E.L., Climatic factors are associated with childhood eczema prevalence in the United States. J Invest Dermatol 133 (2013), 1752–1759.
145. 145 Kim, E.H., Kim, S., Lee, J.H., Kim, J., Han, Y., Kim, Y.M., et al. Indoor air pollution aggravates symptoms of atopic dermatitis in children. PLoS One, 10, 2015, e0119501.
146. 146 Kwon, J.H., Kim, E., Chang, M.H., Park, E.A., Hong, Y.C., Ha, M., et al. Indoor total volatile organic compounds exposure at 6 months followed by atopic dermatitis at 3 years in children. Pediatr Allergy Immunol 26 (2015), 352–358.
147. 147 Lee, C.H., Chuang, H.Y., Hong, C.H., Huang, S.K., Chang, Y.C., Ko, Y.C., et al. Lifetime exposure to cigarette smoking and the development of adult-onset atopic dermatitis. Br J Dermatol 164 (2011), 483–489.
148. 148 Huang, C., Wen, H., Chen, P., Chiang, T., Lin, S., Guo, Y.L., Prenatal air pollutant exposure and occurrence of atopic dermatitis. Br J Dermatol 173 (2015), 981–988.
149. 149 Suarez-Varela, M.M., Gallardo-Juan, A., Garcia-Marcos, L., Gimeno-Clemente, N., Silvarrey-Varela, A.L., Miner-Canflanca, I., et al. The impact of atmospheric pollutants on the prevalence of atopic eczema in 6-7-year-old schoolchildren in Spain; ISAAC Phase III. Iran J Allergy Asthma Immunol 12 (2013), 220–227.
150. 150 Larsen, A.D., Schlunssen, V., Christensen, B.H., Bonde, J.P., Obel, C., Thulstrup, A.M., et al. Exposure to psychosocial job strain during pregnancy and odds of asthma and atopic dermatitis among 7-year old children—a prospective cohort study. Scand J Work Environ Health 40 (2014), 639–648.
151. 151 Peters, E.M., Michenko, A., Kupfer, J., Kummer, W., Wiegand, S., Niemeier, V., et al. Mental stress in atopic dermatitis—neuronal plasticity and the cholinergic system are affected in atopic dermatitis and in response to acute experimental mental stress in a randomized controlled pilot study. PLoS One, 9, 2014, e113552.
152. 152 Schmid-Ott, G., Jaeger, B., Meyer, S., Stephan, E., Kapp, A., Werfel, T., Different expression of cytokine and membrane molecules by circulating lymphocytes on acute mental stress in patients with atopic dermatitis in comparison with healthy controls. J Allergy Clin Immunol 108 (2001), 455–462.
153. 153 Jedrychowski, W., Perera, F., Maugeri, U., Mrozek-Budzyn, D., Miller, R.L., Flak, E., et al. Effects of prenatal and perinatal exposure to fine air pollutants and maternal fish consumption on the occurrence of infantile eczema. Int Arch Allergy Immunol 155 (2011), 275–281.
154. 154 Morales Suarez-Varela, M., Garcia-Marcos, L., Kogan, M.D., Llopis Gonzalez, A., Martinez Gimeno, A., Aguinaga Ontoso, I., et al. Parents’ smoking habit and prevalence of atopic eczema in 6-7 and 13-14 year-old schoolchildren in Spain. ISAAC phase III. Allergol Immunopathol (Madr) 36 (2008), 336–342.
155. 155 Thyssen, J.P., Zirwas, M.J., Elias, P.M., Potential role of reduced environmental UV exposure as a driver of the current epidemic of atopic dermatitis. J Allergy Clin Immunol 136 (2015), 1163–1169.
156. 156 Perkin, M.R., Craven, J., Logan, K., Strachan, D., Marrs, T., Radulovic, S., et al. Association between domestic water hardness, chlorine, and atopic dermatitis risk in early life: a population-based cross-sectional study. J Allergy Clin Immunol, 2016 [Epub ahead of print].
157. 157 McNally, N.J., Williams, H.C., Phillips, D.R., Smallman-Raynor, M., Lewis, S., Venn, A., et al. Atopic eczema and domestic water hardness. Lancet 352 (1998), 527–531.
158. 158 Lack, G., Fox, D., Northstone, K., Golding, J., Avon Longitudinal Study of Parents and Children Study Team. Factors associated with the development of peanut allergy in childhood. N Engl J Med 348 (2003), 977–985.
159. 159 Brough, H.A., Liu, A.H., Sicherer, S., Makinson, K., Douiri, A., Brown, S.J., et al. Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy. J Allergy Clin Immunol 135 (2015), 164–170.
160. 160 Brough, H.A., Simpson, A., Makinson, K., Hankinson, J., Brown, S., Douiri, A., et al. Peanut allergy: effect of environmental peanut exposure in children with filaggrin loss-of-function mutations. J Allergy Clin Immunol 134 (2014), 867–875.e1.
161. 161 Banerjee, S., Resch, Y., Chen, K.W., Swoboda, I., Focke-Tejkl, M., Blatt, K., et al. Der p 11 is a major allergen for house dust mite-allergic patients suffering from atopic dermatitis. J Invest Dermatol 135 (2015), 102–109.
162. 162 Glaser, R., Meyer-Hoffert, U., Harder, J., Cordes, J., Wittersheim, M., Kobliakova, J., et al. The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption. J Invest Dermatol 129 (2009), 641–649.
163. 163 Jin, S., Park, C.O., Shin, J.U., Noh, J.Y., Lee, Y.S., Lee, N.R., et al. DAMP molecules S100A9 and S100A8 activated by IL-17A and house-dust mites are increased in atopic dermatitis. Exp Dermatol 23 (2014), 938–941.
164. 164 Eyerich, K., Bockelmann, R., Pommer, A.J., Foerster, S., Hofmeister, H., Huss-Marp, J., et al. Comparative in situ topoproteome analysis reveals differences in patch test-induced eczema: cytotoxicity-dominated nickel versus pleiotrope pollen reaction. Exp Dermatol 19 (2010), 511–517.
165. 165 Eyerich, K., Huss-Marp, J., Darsow, U., Wollenberg, A., Foerster, S., Ring, J., et al. Pollen grains induce a rapid and biphasic eczematous immune response in atopic eczema patients. Int Arch Allergy Immunol 145 (2008), 213–223.
166. 166 Gilles, S., Behrendt, H., Ring, J., Traidl-Hoffmann, C., The pollen enigma: modulation of the allergic immune response by non-allergenic, pollen-derived compounds. Curr Pharm Des 18 (2012), 2314–2319.
167. 167 Varga, A., Budai, M.M., Milesz, S., Bacsi, A., Tozser, J., Benko, S., Ragweed pollen extract intensifies lipopolysaccharide-induced priming of NLRP3 inflammasome in human macrophages. Immunology 138 (2013), 392–401.
168. 168 Bruchard, M., Rebe, C., Derangere, V., Togbe, D., Ryffel, B., Boidot, R., et al. The receptor NLRP3 is a transcriptional regulator of TH2 differentiation. Nat Immunol 16 (2015), 859–870.
169. 169 Guttman-Yassky, E., Suarez-Farinas, M., Chiricozzi, A., Nograles, K.E., Shemer, A., Fuentes-Duculan, J., et al. Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis. J Allergy Clin Immunol 124 (2009), 1235–1244.e58.
170. 170 Inkeles, M.S., Scumpia, P.O., Swindell, W.R., Lopez, D., Teles, R.M., Graeber, T.G., et al. Comparison of molecular signatures from multiple skin diseases identifies mechanisms of immunopathogenesis. J Invest Dermatol 135 (2015), 151–159.
171. 171 Jutel, M., Agache, I., Bonini, S., Burks, A.W., Calderon, M., Canonica, W., et al. International consensus on allergy immunotherapy. J Allergy Clin Immunol 136 (2015), 556–568.
172. 172 Werfel, T., Biedermann, T., Current novel approaches in systemic therapy of atopic dermatitis: specific inhibition of cutaneous Th2 polarized inflammation and itch. Curr Opin Allergy Clin Immunol 15 (2015), 446–452.
173. 173 Howell, M.D., Parker, M.L., Mustelin, T., Ranade, K., Past, present, and future for biologic intervention in atopic dermatitis. Allergy 70 (2015), 887–896.
174. 174 Thaci, D., Simpson, E.L., Beck, L.A., Bieber, T., Blauvelt, A., Papp, K., et al. Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial. Lancet 387 (2016), 40–52.
175. 175 Oldhoff, J.M., Darsow, U., Werfel, T., Katzer, K., Wulf, A., Laifaoui, J., et al. Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis. Allergy 60 (2005), 693–696.
176. 176 Heil, P.M., Maurer, D., Klein, B., Hultsch, T., Stingl, G., Omalizumab therapy in atopic dermatitis: depletion of IgE does not improve the clinical course—a randomized, placebo-controlled and double blind pilot study. J Dtsch Dermatol Ges 8 (2010), 990–998.
177. 177 Sheinkopf, L.E., Rafi, A.W., Do, L.T., Katz, R.M., Klaustermeyer, W.B., Efficacy of omalizumab in the treatment of atopic dermatitis: a pilot study. Allergy Asthma Proc 29 (2008), 530–537.
178. 178 Simon, D., Hosli, S., Kostylina, G., Yawalkar, N., Simon, H.U., Anti-CD20 (rituximab) treatment improves atopic eczema. J Allergy Clin Immunol 121 (2008), 122–128.
179. 179 Sediva, A., Kayserova, J., Vernerova, E., Polouckova, A., Capkova, S., Spisek, R., et al. Anti-CD20 (rituximab) treatment for atopic eczema. J Allergy Clin Immunol 121 (2008), 1515–1516 author reply 6-7.
180. 180 Puya, R., Alvarez-Lopez, M., Velez, A., Casas Asuncion, E., Moreno, J.C., Treatment of severe refractory adult atopic dermatitis with ustekinumab. Int J Dermatol 51 (2012), 115–116.
181. 181 Samorano, L.P., Hanifin, J.M., Simpson, E.L., Leshem, Y.A., Inadequate response to ustekinumab in atopic dermatitis—a report of two patients. J Eur Acad Dermatol Venereol 30 (2016), 522–523.
182. 182 Buka, R.L., Resh, B., Roberts, B., Cunningham, B.B., Friedlander, S., Etanercept is minimally effective in 2 children with atopic dermatitis. J Am Acad Dermatol 53 (2005), 358–359.
183. 183 Hanifin, J.M., Schneider, L.C., Leung, D.Y., Ellis, C.N., Jaffe, H.S., Izu, A.E., et al. Recombinant interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol 28 (1993), 189–197.